Dong-A Pharm: A Korean Skincare Brand Built on Pharmaceutical Science
A 90-year-old pharmaceutical company whose acne-focused skincare lines come straight out of the pharmacy aisle, not the beauty counter.
Dong-A Pharm is one of South Korea's oldest pharmaceutical companies, and its skincare products reflect that heritage. If you are looking at this Dong-A Pharm Korean skincare brand for the first time, the short version is this: the formulas are rooted in regulated pharmaceutical science, the Acnon line targets active breakouts with disclosed medicinal actives, and the Acne Pro Gel — the product featured on Kayty — brings BHA and AHA exfoliation into a single rinse-off treatment.
Who This Brand Is For
If your skin concern is acne — not dullness, not dryness, not fine lines, but actual breakouts — Dong-A Pharm exists precisely for that problem. The brand does not try to cover every corner of skincare. It comes from a pharmaceutical tradition, and it stays close to it: targeted formulations, disclosed actives, and a focus on oily, congested, or breakout-prone skin. The Acne Pro Gel on Kayty is a good entry point if you are dealing with blackheads, whiteheads, or texture caused by clogged pores, and you want an acid-based treatment rather than a spot cream.
Where the Brand Comes From
Dong-A Pharmaceutical began in December 1932 as a wholesaler of medicines and hygiene materials in Seoul's Jongno district, growing over the following decades into one of South Korea's defining pharmaceutical companies. Its household-name products — the Bacchus energy tonic and the Panpyrin cold remedy — made it a fixture of Korean daily life long before K-beauty became a global category. The company today operates under Dong-A Socio Holdings and spans OTC medicines, quasi-drugs, medical devices, health foods, and cosmetics.
Its move into skincare leverages that pharmaceutical heritage: the Acnon line, whose name fuses "acne" and "non," offers medicated spot treatments aimed at inflamed and cystic breakouts, while the FATION brand positions itself as science-backed derma care for sensitive and compromised skin. Behind the push into skincare is growing demand for dermacosmetics — products rooted in dermatological science. Consumers are increasingly looking beyond brand image to ingredients and efficacy, giving pharmaceutical companies an advantage built on decades of research and technical expertise.
What It Is Known For
Dong-A Pharmaceutical is one of South Korea's oldest and largest pharmaceutical companies. Its skincare lines — including the Acnon acne treatments and the FATION derma range — are extensions of that pharmaceutical base rather than independently celebrated cosmetic labels, and benefit from the company's manufacturing and regulatory infrastructure.
The Acnon line is the older, more pharmacy-rooted of the two. Acnon is Dong-A Pharmaceutical's long-running over-the-counter acne spot cream, a fixture of Korean pharmacies formulated as a medicinal product for red, purulent, individual pimples rather than as a cosmetic. Its main ingredients are ibuprofen piconol, an anti-inflammatory that also targets lipase production in acne bacteria, and isopropyl methylphenol, which hampers the proliferation of acne bacteria — and according to the company, isopropyl methylphenol is present at roughly three times the content found in comparable acne medications.
FATION is Dong-A's more cosmetically oriented derma line. The company describes it as a derma cosmetics brand based on Dong-A Pharmaceutical's skin science expertise, built around what it calls medically validated functional ingredients. Its centerpiece is the Nosca9 line, which began with weak-acid cleansing products and has since grown into pore-care toners, serums, and creams. Dong-A has also pushed FATION into the U.S. market, rolling it out to Sephora stores stateside.
